The protein expression of SLC2A1 was significantly decreased in BRCA, OV, LIHC, and lung cancer, while being increased in COAD, KIRC, UCEC, PAAD, HNSC, and GBM (Figure 5A). This evidence concerns the gene SLC2A1 and lung cancer.